Award
National Cancer Institute 5R01CA257672-04
Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy
Recipient
Beth Israel Deaconess Medical Center
Award Amount
$711,511.00
Ceiling
$711,511.00
Awarded
January 22, 2026
Identifier
5R01CA257672-04
Research project funded by the National Cancer Institute to study PD-1 inhibitory signaling in T cells and its implications for cancer immunotherapy, aiming to identify biomarkers and understand immune regulation in the tumor microenvironment.
Description
This project aims to understand the role of PD-1 signaling in T cells within the tumor microenvironment and its implications for cancer immunotherapy. The study investigates PD-1 signaling in T cells and its impact on cancer immunotherapy outcomes, focusing on biomarker development and immune landscape reshaping.